Evidence map›Paper›PMID 26607722›Full record

ArticlePharmacogenomics2015

The value of control conditions for evaluating pharmacogenetic effects.

Li-Shiun Chen, Timothy B Baker, Laura J Bierut

Abstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmacogenomics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Li-Shiun ChenDepartment of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA.
Timothy B BakerTobacco Research and Intervention, University of Wisconsin, School of Medicine, Madison, WI, USA.
Laura J BierutDepartment of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA.

Funding

RELAPSE: LINKING SCIENCE AND PRACTICEP50CA084724 · NCI · UNIVERSITY OF WISCONSIN MADISON · PI FIORE, MICHAEL C · 1999 to 2003
$8.9M
Tobacco Dependence: Treatment and OutcomesP50DA019706 · NIDA · UNIVERSITY OF WISCONSIN-MADISON · PI JACKSON, THOMAS C · 2004 to 2008
$8.6M
Genetics Study of Nicotine Dependence in African AmericansR01DA025888 · NIDA · WASHINGTON UNIVERSITY · PI BIERUT, LAURA J., JOHNSON, ERIC OTTO · 2009 to 2014
$4.7M
Genetically Informed Smoking Cessation TrialR01DA038076 · NIDA · WASHINGTON UNIVERSITY · PI CHEN, LI-SHIUN · 2014 to 2018
$3.3M
Nicotine Dependence to Smoking Cessation: Sequencing Common and Rare VariantsR01DA036583 · NIDA · WASHINGTON UNIVERSITY · PI BIERUT, LAURA J. · 2014 to 2017
$3.0M
Training in Translational Tobacco ScienceK05CA139871 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI BAKER, TIMOTHY B · 2008 to 2012
$850k
Genetic and Environmental Risks for Smoking Characteristics and CessationK08DA030398 · NIDA · WASHINGTON UNIVERSITY · PI CHEN, LI-SHIUN · 2011 to 2014
$671k
Human Genetics of Addiction: A Study of Common and Specific FactorsK02DA021237 · NIDA · WASHINGTON UNIVERSITY · PI BIERUT, LAURA J. · 2007 to 2011
$567k
NCI NIH HHS K05 CA139871NCI NIH HHS P50 CA084724NCI NIH HHS P50 CA84724NIDA NIH HHS K02 DA021237NIDA NIH HHS K08 DA030398NIDA NIH HHS K08DA030398NIDA NIH HHS P50 DA019706NIDA NIH HHS P50 DA19706NIDA NIH HHS R01 DA025888NIDA NIH HHS R01DA025888NIDA NIH HHS R01 DA036583NIDA NIH HHS R01 DA038076
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Smoking CessationTobacco Use Cessation DevicesGenetic VariationHumansSmoking

Identifiers

PMID26607722
PMCPMC5558525

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.